Irinotecan (CPT-11): clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 3 2
Conditions being studied
| Condition | Trials |
|---|---|
| Colorectal Cancer | 1 |
| Pancreatic Adenocarcinoma Advanced or Metastatic | 1 |
| Pancreatic cancer | 1 |
Recruiting trials involving Irinotecan (CPT-11)
- FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.
- Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.
Common questions
How many recruiting trials involve Irinotecan (CPT-11)?
2 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.